78 related articles for article (PubMed ID: 11980114)
1. [Clinical and biochemical aspects of flixotide administration in patients with moderate bronchial asthma].
Medvedeva IV; Lapik SV; Gur'eva SA; Savina IA
Ter Arkh; 2002; 74(3):21-5. PubMed ID: 11980114
[TBL] [Abstract][Full Text] [Related]
2. beta-adrenergic receptor genotype and response to salmeterol.
Wechsler ME; Israel E
J Allergy Clin Immunol; 2007 Jul; 120(1):218-9; author reply 219-20. PubMed ID: 17399776
[No Abstract] [Full Text] [Related]
3. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of salbutamol and fluticasone for emergency treatment of children with moderate acute asthma.
Estrada-Reyes E; Del Río-Navarro BE; Rosas-Vargas MA; Nava-Ocampo AA
Pediatr Allergy Immunol; 2005 Nov; 16(7):609-14. PubMed ID: 16238587
[TBL] [Abstract][Full Text] [Related]
5. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study.
Pedersen SE; Bateman ED; Bousquet J; Busse WW; Yoxall S; Clark TJ;
J Allergy Clin Immunol; 2007 Nov; 120(5):1036-42. PubMed ID: 17935765
[TBL] [Abstract][Full Text] [Related]
6. [The MMW Drug Prize 2002: Prize for a new classic with innovation potential].
Schultze-Werninghaus G
Med Klin (Munich); 2002 Dec; 97 Suppl 2():1. PubMed ID: 12593173
[No Abstract] [Full Text] [Related]
7. Long-acting beta agonists--prescribe with care.
Crane J
N Z Med J; 2006 Jul; 119(1237):U2064. PubMed ID: 16862206
[No Abstract] [Full Text] [Related]
8. [Serevent in the treatment of moderate bronchial asthma].
Panghea P; Voicu G; Filip G; Arghir O; Floca L; Acasandri E; Mihai D
Pneumoftiziologia; 1996; 45(3-4):145-8. PubMed ID: 9221040
[TBL] [Abstract][Full Text] [Related]
9. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[TBL] [Abstract][Full Text] [Related]
10. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effectiveness of superoxide inhalations and their effects on crystalline structure and antiradical defense of blood serum and expired air condensate in patients with bronchial asthma].
Nikitin AV; Zuĭkova AA
Ter Arkh; 2001; 73(3):20-3. PubMed ID: 11417174
[TBL] [Abstract][Full Text] [Related]
12. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
[TBL] [Abstract][Full Text] [Related]
13. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the combination of fluticasone propionate and salmeterol in patients with moderate persistent asthma within a "real-life" setting.
Trautmann M; Banik N; Tews JT; Jörres RA; Nowak D
Eur J Med Res; 2007 Jun; 12(6):255-63. PubMed ID: 17666315
[TBL] [Abstract][Full Text] [Related]
15. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
16. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
17. Evidence based answers--is salmeterol safe in asthma?
Spurling G; Doust J
Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
[No Abstract] [Full Text] [Related]
18. [Asthma control with the salmeterol-fluticasone-combination disc compared to standard treatment].
Molitor S; Liefring E; Trautmann M
Pneumologie; 2005 Mar; 59(3):167-73. PubMed ID: 15756629
[TBL] [Abstract][Full Text] [Related]
19. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
[TBL] [Abstract][Full Text] [Related]
20. [Effects of combined therapy with domestic inhalational anti-asthmatic drugs on oxidant status of patients with bronchial asthma].
Kolpakova AF
Ter Arkh; 2007; 79(3):41-4. PubMed ID: 17526195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
